A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021)

NCT01717300 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

459

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Anacetrapib 100 mg
DRUG: Placebo for anacetrapib 100 mg
DRUG: Anacetrapib 25 mg
DRUG: Placebo for anacetrapib 25 mg

Sponsor

Merck Sharp & Dohme LLC